Crossmark

Vortioxetine: A new alternative for the treatment of major depressive disorder

Crossref DOI link: https://doi.org/10.1016/j.rpsmen.2018.02.005

Published Print: 2018-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Salagre, Estela

Grande, Iria

Solé, Brisa

Sanchez-Moreno, Jose

Vieta, Eduard
Funding

Funding for this research was provided by:

Carlos III Health Institute, the Spanish Ministry of Economy, Industry and Competitiveness (PI16/00187)

Centre for Biomedical Research into the Mental Health Network (CIBERSAM)

Grups Consolidats de Recerca 2014

Seventh European Framework Programme (ENBREC)
License Information

Text and Data Mining valid from 2018-01-01
More Information

This article is maintained by: Elsevier

Article Title: Vortioxetine: A new alternative for the treatment of major depressive disorder

Journal Title: Revista de Psiquiatría y Salud Mental (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.rpsmen.2018.02.005

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.rpsm.2017.06.006

Content Type: article

Copyright: © 2017 SEP y SEPB. Published by Elsevier España, S.L.U. All rights reserved.